A detailed history of Capital International Investors transactions in Insmed Inc stock. As of the latest transaction made, Capital International Investors holds 6,523,791 shares of INSM stock, worth $477 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,523,791
Previous 5,869,888 11.14%
Holding current value
$477 Million
Previous $393 Million 21.09%
% of portfolio
0.09%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $40.5 Million - $51.7 Million
653,903 Added 11.14%
6,523,791 $476 Million
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $93.5 Million - $296 Million
4,249,074 Added 262.16%
5,869,888 $393 Million
Q1 2024

May 14, 2024

BUY
$25.72 - $29.94 $41.7 Million - $48.5 Million
1,620,814 New
1,620,814 $44 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.91B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.